CONA
TEVA icon

Capital One National Association’s Teva Pharmaceuticals TEVA Stock Holding History

Capital One National Association’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$279K Hold
11,461
– – 0.02% 425
2018
Q1 		$196K Sell
11,461
-291
-2% -$5.68K 0.01% 497
2017
Q4 		$223K Buy
11,752
+382
+3% +$5.75K 0.02% 485
2017
Q3 		$200K Buy
11,370
+3,397
+43% +$76.4K 0.01% 510
2017
Q2 		$265K Buy
+7,973
New +$247K 0.02% 449
2013
Q4 		– Sell
-7,967
Closed -$301K – 578
2013
Q3 		$301K Sell
7,967
-916
-10% -$35.7K 0.03% 417
2013
Q2 		$348K Buy
+8,883
New +$346K 0.04% 353

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Capital One National Association's TEVA Position: Q2 2018 in Review

Capital One National Association held its Teva Pharmaceuticals (TEVA) position steady in Q2 2018 at 11,461 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #425.

Capital One National Association first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. The position peaked at $348K in Q2 2013. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • Capital One National Association held 11,461 shares of Teva Pharmaceuticals worth $279K as of Q2 2018.
  • Capital One National Association left its Teva Pharmaceuticals share count unchanged in Q2 2018.
  • Teva Pharmaceuticals made up 0.02% of Capital One National Association's portfolio in Q2 2018, its #425 holding.
  • Capital One National Association first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • Capital One National Association's Teva Pharmaceuticals position peaked at $348K in Q2 2013.
  • 539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.